Acoziborole: Investigational Single-Dose Oral Treatment Raises Hope for Elimination of Sleeping Sickness in Africa
Acoziborole: Investigational single-dose oral treatment raises hope for elimination of sleeping sickness in Africa
Positive Phase II/III study results support acoziborole’s potential in treatment for deadly... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - November 30, 2022 Category: Pharmaceuticals Source Type: clinical trials
Prospective Evaluation of the Specificity of Serological Tests for Human African Trypanosomiasis
Conditions:  Human African Trypanosomiasis;  Sleeping Sickness;  Trypanosoma Brucei Gambiense; Infection;  West African Sleeping Sickness Interventions:  Diagnostic Test: Serological field test for HAT;  Diagnostic Test: malaria rapid test;  Diagnostic Test: Immunologic laboratory tests;  Diagnostic Test: Molecular laboratory tests Sponsors:  Institut de Recherche pour le Developpement;  Foundation for Innovative New Diagnostics;  Programme National de lutte contre la THA, Guinée;  Université Jean Lorougnon Guédé, Daloa;  Institut Pasteur, GuinÃ...
Source: ClinicalTrials.gov - July 20, 2022 Category: Research Source Type: clinical trials
Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP3 Post Elimination Monitoring
Conditions:  Human African Trypanosomiasis;  Sleeping Sickness;  Trypanosoma Brucei Gambiense; Infection;  West African Sleeping Sickness;  African Trypanosomiases;  Trypanosomiasis; African, Due to Trypanosoma Brucei Gambiense, Gambiense Intervention:  Diagnostic Test: Rapid diagnostic test (RDT); Serological and molecular tests on DBS Sponsors:  Institut de Recherche pour le Developpement;  Ministry of Public Health, Democratic Republic of the Congo;  Institut National de Sante Publique, Côte d'Ivoire;  CIRDES, Burkina Faso;  Institut National de Recherche Biomédicale. Kinshasa,...
Source: ClinicalTrials.gov - September 23, 2019 Category: Research Source Type: clinical trials